Immediate Postpartum Glucose Tolerance Testing
MemorialCare Health System · NCT04199676
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 300
- US sites recruiting
- 1
- Study start
- September 1, 2020
- Record last updated
- September 3, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.
Being studied: Glucose tolerance test
Conditions: Gestational Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pregnant or recently postpartum (postpartum day 0 or 1)
- ≥ 18 years of age
- Gestational age ≥34 weeks
- A1 or A2 gestational diabetes
Exclusion Criteria
- Medical exclusion from completing glucose tolerance testing
- Steroid administration within 10 days prior to enrollment
- Chronic steroid use
Recruiting US locations
Long Beach Memorial Medical Center/Miller Children's and Women's Hospital
Long Beach, CA 90806
Site contact: Alice Sherman-Brown, MD · 562-997-8510 · alicebrown092@gmail.com
Study contacts (from the official record)
- Alice Sherman-Bron, MD · (562) 997-8510 · alicebrown092@gmail.com
Similar studies in California
All diabetes studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
TIXiMED, Inc.
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Regeneron Pharmaceuticals
- Location
- Glendale, CA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Glendale, CA + 3 other US sites
- Eligibility basics
- Ages 18–75